Completed

2

2

Europe

Eltrombopag (Revolade®), standard therapy (without eltrombopag): HD-DXM

University Children's Hospital Basel, Stiftung zur Förderung medizinischer und biologischer Forschung, Novartis Pharmaceuticals, University of Erlangen-Nürnberg, Department of Biology

Primary Immune Thrombocytopenia (ITP)

04/24

04/24